Skip to content

A Digital Lifestyle Intervention in Primary Healthcare to Prevent Cardiovascular Disease

A Digital Lifestyle Intervention in Primary Healthcare to Prevent Cardiovascular Disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06847633
Enrollment
1000
Registered
2025-02-26
Start date
2025-03-03
Completion date
2027-12-01
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Lifestyle Factors

Brief summary

Unhealthy lifestyle behaviors are well-established risk factors for cardiovascular disease (CVD) which is the leading cause of death globally and in Sweden. Digitalization offers new and better possibilities for healthcare to fulfil their responsibility to support healthier lifestyles, however, to ensure scalability and sustained implementation of digital tools within healthcare, digital interventions need to be systematically maintained and delivered by the primary healthcare. The aim of this project is to evaluate whether a digital lifestyle intervention, developed within Swedish primary healthcare, can improve clinically important cardiovascular health outcomes and lifestyle behaviors. In this multi-center randomized controlled trial patients, 40-60 years, in Swedish primary healthcare will be recruited and randomized to the control or intervention group. All participants will receive standard care consisting of one structured health dialogue focused on lifestyle habits. The intervention group will also receive support through the digital lifestyle intervention for creating healthy habits regarding diet, physical activity, alcohol consumption, and tobacco usage. The primary outcome is LDL-cholesterol at 6 months post-randomization. Secondary outcomes 6 months post-randomization are HDL-, total cholesterol, fasting blood glucose, triglycerides, non-HDL, blood pressure, weight, height, BMI, waist circumference, cardiovascular risk evaluation (SCORE2), dietary intake, physical activity, sleep, stress, alcohol consumption, tobacco use, and health-related quality of life.

Interventions

The digital lifestyle intervention provides support to the patient through digital lectures, home assignments and digital group meetings as well as provides the possibility for the healthcare provider to provide personalized digital support and feedback to the patient

Sponsors

Karolinska Institutet
Lead SponsorOTHER
Capio Narsjukvard
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
39 Years to 61 Years
Healthy volunteers
No

Inclusion criteria

* Attended a Health dialogue visit to primary healthcare for patients 40-60 years old * Willing to change at least one lifestyle behavior regarding physical activity, diet, smoking/snus, alcohol, sleep, or stress

Exclusion criteria

* diabetes * heart failure * history of myocardial infarction * history of stroke * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
LDL-cholesterol6 months post-randomizationLow density lipoprotein cholesterol

Secondary

MeasureTime frameDescription
HDL-cholesterol6 months post-randomizationHigh density lipoprotein cholesterol
Total cholesterol6 months post-randomization
Fasting blood glucose6 months post-randomization
Triglycerides6 months post-randomization
Non-HDL cholesterol6 months post-randomizationCalculated by subtracting HDL cholesterol from total cholesterol
Systolic blood pressure6 months post-randomization
Diastolic blood pressure6 months post-randomization
Weight6 months post-randomization
Height6 months post-randomization
Body mass index6 months post-randomization
Waist circumference6 months post-randomization
Systematic COronary Risk Evaluation model, second version (SCORE2)6 months post-randomizationEstimated percentage risk of fatal and non-fatal cardiovascular disease within the next 10 years. The estimation is based on data on sex, age, smoking, systolic blood pressure (SBP), total cholesterol, and HDL cholesterol
Health-related quality of life6 months post-randomizationMeasured by the questionnaire EuroQol-5 Dimensions-5 Levels (EQ-5D-5L). Five dimensions including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response options, scored 1-5, ranging from 'no problems' to 'extreme problems'
Diet intake6 months post-randomizationAssessed by questions on intake quantity of vegetables, fruit, sweet beverages, and snacks the past week
Physical activity6 months post-randomizationAssessed by questions on time (minutes and hours) spent in moderate and vigorous physical activity the past week
Sedentary time6 months post-randomizationOne question about time in sitting position
Stress6 months post-randomizationAssessed by the Perceived Stress Scale. Minimum value 0. Maximum value 56. Higher scores indicating greater perceived stress.
Sleep6 months post-randomizationAssessed by the Karolinska Sleep Questionnaire. No single set of minimum and maximum values. Each item is scored from 0-5, where higher values indicate greater sleep issues
Alcohol consumption6 months post-randomizationQuestions on monthly frequency of heavy episodic drinking, weekly alcohol consumption
Tobacco use6 months post-randomizationQuestions on frequency of smoking and using snus the past week and the past 4 weeks
Mediated effects on behavior change6 months post-randomizationPotential mediators to be assessed are confidence, importance, and know-how (i.e., knowing how to change a behavior).
Participant experience from using the digital intervention6 months post-randomizationQuestions on experience from using the intervention (intervention group only). The questions are framed as statements with five response options ranging from 'Not agreeing at all' to 'Fully agreeing'

Countries

Sweden

Contacts

CONTACTLinnea Hedin, PhD
linnea.hedin@ki.se+4670-2473149
PRINCIPAL_INVESTIGATORMarie Löf, PhD

Karolinska Institutet

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026